A REVIEW OF ALZHEIMER’S DISEASE FORMATION, DIAG-NOSIS AND TREATMENT

Authors

  • Xueer Wang Cardiff Sixth Form College, Cardiff, United Kingdom

DOI:

https://doi.org/10.20319/mijst.2020.61.4557

Keywords:

Dementia, Alzheimer’s Disease, Beta-Amyloid, Tau Proteins, Cognitive Functions, MCI

Abstract

Alzheimer’s disease is one prevalent form of dementia associated with ageing, which is affecting approximately 1.3% of the UK population. Although the exact cause of Alzheimer’s disease remains unknown, it is widely accepted that the abnormal aggregation of proteins in the nervous system could be the primary cause resulting in this disease by damaging brain cells, and other risk factors also exist to increase the chances of having this disease such as ageing and a low education level. There are three possible distinct clinical phases in individuals with Alzheimer’s disease pathology: asymptomatic, mild cognitive impairment and Alzheimer’s disease. The symptoms of Alzheimer’s disease progression worsen gradually over several years which generally involve memory loss, motor coordination problems and inability to perform routine daily tasks. Because Alzheimer’s disease has a negative impact on not only the diagnosed patients but also their family members and the whole society, it is clear that treatment of this disease is required urgently. However, there is no current cure for Alzheimer’s disease but the symptoms can be managed and even moderated by a cohort of drugs as well as some protective factors. For example, aiming at various pathological symptoms of Alzheimer’s disease, different drugs have been investigated to resolve specific problems, thus help to control and alleviate the symptoms such as memory loss. There are also studies that discover numerous protective factors, which can reduce the risk of developing Alzheimer’s disease like a high education level and regular physical activities. Despite all the research and findings, the progress on Alzheimer’s disease is slow, and the prevention method is yet to be found, which means more attention and effort is needed to find an effective cure for this disease.

References

About dementia. (2017). Retrieved 21 June 2019, from https://www.nhs.uk/conditions/dementia/about/

Alzheimer’s disease - Diagnosis and treatment - Mayo Clinic. (2020). Retrieved 7 January 2020, from https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/diagnosis-treatment/drc-20350453

Alzheimer's disease: How effective are cholinesterase inhibitors?. (2020). Retrieved 16 June 2019, from https://www.ncbi.nlm.nih.gov/books/NBK279358/

Alzheimers.org.uk. (2014). [online] Available at: https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/dementia_uk_update.pdf [Accessed 25 Jun. 2019

Bali, J., Gheinani, A., Zurbriggen, S., & Rajendran, L. (2012). Role of genes linked to sporadic Alzheimer's disease risk in the production of -amyloid peptides. Proceedings of the Na-tional Academy Of Sciences, 109(38), 15307-15311. https://doi.org/10.1073/pnas.1201632109

Bradshaw, J. (2004). Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct. Journal of Neurology, Neurosurgery & Psychiatry, 75(3), 382-387. https://doi.org/10.1136/jnnp.2002.002576

Cleveland Clinic Center for Continuing Education. Retrieved 8 January 2020, from http://www.clevelandclinicmeded.com

C, P. (2018). Alzheimer's: How does tau disrupt brain cells?. Retrieved 24 June 2019, from https://www.medicalnewstoday.com/articles/322991.php

C, P. (2019). Alzheimer's blood test detects brain damage years before symptoms. Retrieved 17 June 2019, from https://www.medicalnewstoday.com/articles/324244.php

Contributor, N., & Contributor, N. (2014). Differentiating dementia, delirium and depression | Nursing Times. Retrieved 6 June 2019, from https://www.nursingtimes.net/roles/mental-health-nurses/differentiating-dementia-delirium-and-depression/5084104.article

Core Journal. (2006). Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes. Core Evidence, Volume 1-Issues 3 & 4, 0-0. https://doi.org/10.2147/CE.S7447

D, C. (2016). Quest to find cure for Alzheimer’s shows symptoms of failure | Financial Times. Re-trieved 29 June 2019, from https://www.ft.com/content/ec01d882-b618-11e6-ba85-95d1533d9a62

Dementia Statistics Hub. (2019). Different typesof dementia | Dementia Statistics Hub. [online] Available at: https://www.dementiastatistics.org/statistics/different-types-of-dementia/ [Accessed 24 Jun. 2019]

Dementia UK report. (2014). Retrieved 16 June 2019, from https://www.alzheimers.org.uk/about-us/policy-and-influencing/dementia-uk-report

Desmyter, S., van Heeringen, C., & Audenaert, K. (2011). Structural and functional neuroimaging studies of the suicidal brain. Progress In Neuro-Psychopharmacology And Biological Psy-chiatry, 35(4), 796-808. https://doi.org/10.1016/j.pnpbp.2010.12.026

Findeis, M. (2007). The role of amyloid β peptide 42 in Alzheimer's disease. Pharmacology & Therapeutics, 116(2), 266-286. https://doi.org/10.1016/j.pharmthera.2007.06.006

Green, R., Goldstein, F., Mirra, S., Alazraki, N., Baxt, J., & Bakay, R. (1995). Slowly progressive apraxia in Alzheimer's disease. Journal Of Neurology, Neurosurgery & Psychiatry, 59(3), 312-315. https://doi.org/10.1136/jnnp.59.3.312

Grimm, A., Lim, Y., Mensah-Nyagan, A., Götz, J., & Eckert, A. (2012). Alzheimer's Disease, Oes-trogen and Mitochondria: an Ambiguous Relationship. Molecular Neurobiology, 46(1), 151-160. https://doi.org/10.1007/s12035-012-8281-x

Gu, J., Fischer, C., Saposnik, G., & Schweizer, T. (2013). Profile of Cognitive Complaints in Vas-cular Mild Cognitive Impairment and Mild Cognitive Impairment. ISRN Neurology, 2013, 1-6. https://doi.org/10.1155/2013/865827

Henderson, V., Mack, W., & Williams, B. (1989). Spatial Disorientation in Alzheimer's Disease. Archives of Neurology, 46(4), 391-394. https://doi.org/10.1001/archneur.1989.00520400045018

How do drugs for Alzheimer's disease work?. (2019). Retrieved 15 June 2019, from https://www.alzheimers.org.uk/about-dementia/treatments/drugs/how-do-drugs-alzheimers-disease-work

How is education linked to Alzheimer's progress?. (2019). Retrieved 18 June 2019, from https://www.medicalnewstoday.com/articles/325452.php

Janßen, I., Sturtz, S., Skipka, G., Zentner, A., Garrido, M., & Busse, R. (2010). Ginkgo biloba in Alzheimer’s disease: a systematic review. Wiener Medizinische Wochenschrift, 160(21-22), 539-546. https://doi.org/10.1007/s10354-010-0844-8

J, T., & C, L. (2018). Alzheimer's disease: Symptoms, stages, causes, and treatment. Retrieved 24 June 2019, from https://www.medicalnewstoday.com/articles/159442.php

Kametani, F., & Hasegawa, M. (2018). Reconsideration of Amyloid Hypothesis and Tau Hypothe-sis in Alzheimer's Disease. Frontiers in Neuroscience, 12. https://doi.org/10.3389/fnins.2018.00025

Khachiyants, N., & Y. Kim, K. (2012). Mini-mental status exam mapping to the corresponding brain areas in dementia. Applied Technologies And Innovations, 7(2), 55-58. https://doi.org/10.15208/ati.2012.7

Kirshner, H. (2012). Primary Progressive Aphasia and Alzheimer’s Disease: Brief History, Recent Evidence. Current Neurology and Neuroscience Reports, 12(6), 709-714. https://doi.org/10.1007/s11910-012-0307-2

Morgan, J. (2016). “A big decision”: living with early onset familial Alzheimer's disease. The Lancet Neurology, 15(7), 671. https://doi.org/10.1016/S1474-4422(15)00354-3

Nourhashémi, F., Gillette-Guyonnet, S., Andrieu, S., Ghisolfi, A., Ousset, P., & Grandjean, H. et al. (2000). Alzheimer disease: protective factors. The American Journal Of Clinical Nutrition, 71(2), 643S-649S. https://doi.org/10.1093/ajcn/71.2.643s

Risk factors and prevention. (2019). Retrieved 18 June 2019, from https://www.alzheimers.org.uk/about-dementia/risk-factors-and-prevention

Sauer, A., & Sauer, A. (2020). Risk Factors for Alzheimer's. Retrieved 7 January 2020, from https://www.alzheimers.net/risk-factors-for-alzheimers/

Shampo, M., Kyle, R., & Steensma, D. (2013). Alois Alzheimer–Alzheimer Disease. Mayo Clinic Proceedings, 88(12), e155. https://doi.org/10.1016/j.mayocp.2013.01.031

Symptoms of vascular dementia. (2019). Retrieved 24 June 2019, from https://www.alzheimers.org.uk/about-dementia/types-dementia/symptoms-vascular-dementia

The Different Types of Dementia | Join Dementia Research News. (2017). Retrieved 24 June 2019, from https://news.joindementiaresearch.nihr.ac.uk/different-types-dementia/

Wittenberg, R., Knapp, M., Hu, B., Comas-Herrera, A., King, D., & Rehill, A. et al. (2019). The costs of dementia in England. International Journal Of Geriatric Psychiatry, 34(7), 1095-1103. https://doi.org/10.1002/gps.5113

Downloads

Published

2020-04-20

How to Cite

Wang, X. (2020). A REVIEW OF ALZHEIMER’S DISEASE FORMATION, DIAG-NOSIS AND TREATMENT . MATTER: International Journal of Science and Technology, 6(1), 45–57. https://doi.org/10.20319/mijst.2020.61.4557